Other common sintilimab-related AEs were pyrexia (n = 15, 28.8%), increased aspartate aminotransferase and alanine aminotransferase (n = 16, 30.8%), hypothyroidism (n = 12, 23.1%), rash (n = 18, 34.6%), and pneumonitis (n = 7, 13.5%). This evidence concerns the gene GPT and pneumonitis.